Positive Safety Profile Reported for Atezolizumab/Axi-Cel Combo in DLBCL

Interim safety results of a study investigating the combination of CAR T therapy axicabtagene ciloleucel and atezolizumab for treatment of relapsed diffuse large b-cell lymphoma.